| FEURX | FGDCX | FEURX / FGDCX | |
| Total Expense Ratio | 0.83 | 1.72 | 48% |
| Annual Report Gross Expense Ratio | 0.83 | 1.72 | 48% |
| Fund Existence | 9 years | 19 years | - |
| Gain YTD | 101.827 | 122.309 | 83% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.95B | 3.41B | 145% |
| Annual Yield % from dividends | 2.86 | 1.31 | 219% |
| Returns for 1 year | 96.23 | 119.96 | 80% |
| Returns for 3 years | 149.98 | 159.80 | 94% |
| Returns for 5 years | 111.46 | 83.25 | 134% |
| Returns for 10 years | N/A | 323.29 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| WHIAX | 5.94 | N/A | N/A |
| Macquarie High Income Fund Class A | |||
| JVAYX | 39.88 | -0.36 | -0.89% |
| JPMorgan Value Advantage R6 | |||
| AMTAX | 10.72 | -0.11 | -1.02% |
| AB All Market Real Return A | |||
| FRLAX | 17.17 | -0.21 | -1.21% |
| Franklin Real Estate Securities Adv | |||
| LYFIX | 15.31 | -0.20 | -1.29% |
| AlphaCentric Life Sciences & Hlthcare I | |||